Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Angion Biomedica, Arch Biopartners, Bioaegis, Biontech, Cstone, Cytodyn, Eli Lilly, Enlivex, Everest Medicines, Humanigen, Idorsia, Innovent Biologics, Kamada, Ligand, Novavax, Oncolys, Pharming, Shanghai Fosun, Tessa.